Clinical evidence dossier
Semaglutide
All-cause mortality
Evidence signal
Authoritative evidence signal
strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 6
- Supporting studies available for review
- 6
- Randomized trials
- 6
- Reported effects
- 3
Clinical conclusion
Semaglutide has a small positive evidence signal for All-cause mortality, but the clinical interpretation is limited.
The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.
Observed effects
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 0
- Magnitude-eligible effects
- 0
Consistency
Authoritative consistency classification
mixed
- Positive
- 3
- No effect
- 3
- Mixed
- 0
- Negative
- 0
Population and applicability
Structured population data were available for 6 of 6 supporting studies. 4 studies described participants with type 2 diabetes. 6 studies described adult participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Adults diagnosed with type 2 diabetes.
- Patients at risk for cardiovascular events.
- Adults with type 2 diabetes.
- Individuals at high cardiovascular risk.
- Adults with high cardiovascular risk.
- Patients with diabetes and renal impairment.
- Patients with chronic kidney disease.
- Adults with overweight or obesity.
- Individuals with established cardiovascular disease without diabetes.
- Individuals at high risk for cardiovascular events.
Limitations
- Upstream consistency scoring indicates mixed findings across the evidence.
- 4 supporting studies do not have a displayable topic-matched quantitative effect.
- 1 supporting study has high, serious, critical, unclear, or unavailable risk-of-bias information.
- 1 study contains conflicting p-value and significance fields; those significance claims are suppressed.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.